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Abstract
PP2A is protein phosphatase-2A. Inhibition of PP2A (by PP2A inhibitors 1 and
2) results in hyperphosphorylation and accumulation of tau protein. Hyperphosphorylated tau is
a major component of neurofibrillary tangles – a pathological hallmark of Alzheimer’s Disease
(AD). Hence PP2A inhibition represents a putative new approach for a rodent model of AD.
The goal of this study was to evaluate the effects of PP2A inhibition on dendritic branching in
cortical pyramids in rats that wereinjected ICV with an adeno- associated virus for expression of:
(1) Inhibitor 1 full length (I1 FL)
(2) Inhibitor 2 full length (I2 FL)
(3) Inhibitor 2 amino terminal fragment (I2 NTF)
(4) GFP (Green Fluorescent Protein), Control
Rat brains were subsequently Golgi stained and from coded slides randomly selected layer V
pyramids were evaluated for the amount and distribution of their basilar dendritic arbor using
Sholl analysis. Results showed that administration of both I2 groups (full length and amino
terminal fragment) resulted in more dendritic branching than either the GFP control or the I1 full
length inhibitor. Tau hyperphosphoryation by PP2A-inhibition did not result in a diminution of
cortical branching. Additional studies are ongoing to further characterize the validity of this
model.
Background Alzheimer’s disease, also known as AD, is the most common form of dementia in
the elderly population; with the elderly population being defined as those individuals 65 years
old or greater. By 2010, AD has been known to effect 5 million people throughout the United
States and 30 million people throughout the world (10). It is predicted that by the year 2050
approximately 1 person out of every 85 persons will suffer from AD (1). The cause and course of
AD is still not fully understood, though some basic facts about AD are a consensus between
researchers. AD has two major hallmarks in the brain: extracellular deposits of β-amyloid in
neuritic plaques and intracellular neurofibrillary tangles (NFT) (8). The NFTs and β-amyloid in
neuritic plaques are most often found in the hippocampus, fundus of the forebrain, and the
cerebral cortex of the brain (10).
Both β-amyloid in neuritic plaques as well as NFTs are easily visible using basic
microscopy techniques in brains suffering from AD. β-amyloid in neuritic plaques, often
referred to as just amyloid plaques, are dense mostly extracellular insoluble deposits of amyloidbeta peptide deposited outside and around neurons (8). NFTs are aggregates of
hyperphosphorylated tau, a microtubule-associated protein. The presence of the protein tau is
also found in a great deal of other diseases known as tauopathies. NFTs are formed

by hyperphosphorylation of a microtubule-associated protein (MAP) known as tau, causing it to
aggregate, or group, in an insoluble form (4). The clusters or aggregates of hyperphosphorylated
tau are also referred to as paired helical fragments (PHF). Tau in PHFs is rid of its normal
function as it is abnormally hyperphosphorylated. Tau proteins are proteins that stabilize
microtubules. When tau protein is hyperphosphorylated evidence from several previous studies
have shown that tau loses its biological ability to stabilize microtubules effectively and becomes
quite resistant to proteolytic degradation (2, 3, 5, and 10). Since hyperphosphorylated tau results
in it becoming quite resistant to degradation in comparison to normal tau, there is an
accumulation of tau in tauopathic disease models, such as AD. Tau proteins are quite abundant
in the central nervous system (CNS) and especially in neurons.
Naturally the regulation of the phosphorylation of the tau protein would be of primary
concern when understanding AD and why NFTs develop. It is thus essential then to understand
why and how tau is abnormally hyperphosphorylated. Evidence from previous studies show that
all of the phosphorylation sites on tau are on two amino acid residues: serine and threonine (2).
Previous studies have thus suggested that protein phosphatases (PP) are involved in the
regulation of the phosphorylation of tau (2 ). There are four classes of PP: PP1, PP2A, PP2B, and
PP2C (9). More recent studies have shown that the specific activity of PP2A is the major
regulator of phosphorylation of tau (2). Successful and proper inhibition of PP2A has been
shown to cause hyperphosphoryaltion of tau, and as a result the accumulation of tau and the
development of PHFs and NFTs; and thus a novel way to develop a tauopathy rat model of AD
(3).
In the present study, adeno-associated viruses serotype 1 (AAV1) vectors were used to
express the three different inhibitors used in the experiment: full length (I1 FL), inhibitor 2 full
length (I2 FL), inhibitor 2 amino terminal fragment (I2 NTF), and GFP (Green Fluorescent
Protein) which was used as the control in this experiment. The AAV1 was injected into the
female Wistar rats within their first 24 hours of life intracerebroventricularly (ICV). Three
different cell populations were measured for assessment using sholl analysis after Golgi stained:
granule cells of the dendate gyrus, CA1 pyramids of the hippocampus, and layer V pyramidal
cells of the parietal cortex.
In the present study our laboratory focused predominantly on the morphologhy and the
alterations in the dendritic arbor of three different neuronal populations, and not on the molecular
and mechanistic aspect involving the adeno-associated virus and how the inhibitors were
expressed. To view these different neuronal populations and evaluate them a drawing tube
attached to a Zeiss brightfield microscope was used. The rat brains were required to be stained
using a technique known as Golgi staining or the Golgi method. Golgi staining is a nervous
tissue staining technique discovered by the physician and scientist Camillo Golgi in 1873. Golgi
staining is often the method of choice when examing the morphology of neurons as this
particular study does. Cells in the nervous system are densely packed and thus sometimes hard to
view and distinguish from one another. The uniqueness of the Golgi method stems from them
fact that the staining technique only stains a small percentage of the neuronal elements, allowing
the ability to discern different cells and structures, and their interconnections (7). The Golgi
method itself is capricious and stains a limited number of cells at random in a portion of brain
tissue. The Golgi method randomly stains approximately 8% of all the neurons in the brain,
staining the soma, entire dendriric arbor (95% of the volume of the neuron is made up of the

dendritic arbor), and dendritic spines of the neurons (7). Many times when employing the Golgi
method, one section of brain tissue can be successfully stained while a neighboring portion of
brain tissue might not be stained at all (7). The mechanism by which the Golgi method stains at
random is still largely unknown. The main strength of using the Golgi method is that in regions it
does stain, virtually all of these components are visible, giving a view that captures the entirety
of the neural element. In the present study it is important to note that the morphology of the
neuronal populations examined were a snapshot of what their morphology appeared to be when
the female Wistar rats were between 11 to 13 months of age, with the average being 12 months
in age.
Materials/Methods Formalin fixed brains of four groups of rat brains were sent to
Neurostructural Research Labs. Coronal blocks of tissue incorporating the hippocampus and
overlying parietal cortex were stained using the Rapid Golgi method. Briefly, the tissue blocks
are immersed in a solution of potassijm dichromate and osmium tetroxide for 5-7 days. The
tissue is rinsed in a freshly prepared solution of silver nitrate and placed in more silver nitrate for
39-42 hours. The tissue blocks are dehydrated through ascending concentrations of alcohol, then
into ether-alcohol. The blocks are then embedded in low viscosity nitrocellulose which is
hardened by exposure to choloroform vapors. The hardened blocks are affixed to wooden blocks
and sectioned on an AO sliding microtome at 120um. The sections are cleared in alphaterpineol, throroughly rinsed in xylene, placed on coded slides, and coverslipped under
Permount.
CA1 Branching: Sholl Analysis
CA1 pyramids were randomly selected from coded slides. Camera lucida drawings were
prepared from the basilar tree of the selected CA1s. Neurons had to be well impregnated, not
obscured by other neurons, glia, blood vessels, or non-descript precipitate. Neurons had to be
located in the middle third of the thickness of the slide. The camera lucida drawings were
quantified using Sholl analysis. The Sholl analysis, also known as the Method of Concentric
Circles, defines the amount and distribution of the dendritic tree. In the Sholl analysis, a
template composed of concentric circles of increasing diameters equivalent to 10 microns apart
is superimposed on the camera lucida drawing and the number of intersections of the dendritic
branches with each of the shells is recorded.

Figure 1. Example of a camera lucida drawing with the overlying Sholl template
The data that is generated from this Sholl analysis (or “Method of Concentric Circles”)
provides a profile of the amount and distribution of the dendritic arbor at increasing distances
from the cell body. In addition to the analysis of the CA1s previously described, we also
evaluated the dendritic branching of the granule cells of the dendrite gyrus as well as the layer V
pyramid cells of the parietal cortex. The identical protocol was followed for analyzing this cell
population as we did with the CA1s …e.g., all slides were coded and granule cells and layer V
pyramids were selected at random for preparation and analysis of camera lucida drawings of the
granule cells.

Figure 2. Example of a camera lucida drawing of a granule cell that was prepared for
subsequent Sholl analysis

Statistical Analysis
Statistical analyses were performed using the one-way analysis of variance (ANOVA)
test, and post-hoc analysis with the Bonferroni multiple comparison test. Statistical significance
was accepted at the 95% confidence level( P<0.05).
Results and Conclusions
This study endeavors to characterize a novel disease-relevant nontransgenic model of Alzheimer’s disease based on the adeno- associated viral inhibition of
protein phosphatase 2A (PP2A). This inhibition, by inhibitors 1 and 2, results in
hyperphosphorylation and accumulation of tau protein (as neurofibrillary tangles), which is a
pathological hallmark of AD. Three different inhibitors were evaluated by examining their
effects on dendritic branching from both cortical and hippocampal populations.
For the first cell population studied, the granule cells of the dendate gyrus were injected
with AAVexpressing the three inhibitors, as well as the GFP control. The dendrite gyrus region,
part of the hippocampal formation expressing inhibitor 1 – Full Length (I1 FL) had granule cells
with the largest dendritic arbor at 23% greater than the GFP which was significant.

Figure 3. Granule cells of the dendrite gyrus were injected ICV with AAV expressing:
Inhibitor 1 full length (I1 FL), Inhibitor 2 full length (I2 FL), Inhibitor 2 amino terminal

fragment (I2 NTF), and GFP (Green Fluorescent Protein) Control. GFP control is always
set as 100% for number of intersections per sholl as a standard.
Expression of Inhibition and Total Amount of Dendritic Arbor Length of Granule Cells
of the Dendreate Gyrus
Expression

Total Amount of Dendritic Length

GFP

100%

I1 FL

123%

I2 FL

104%

I2 TNF

91%

Table 1. The total amount of dendritic length was calculated using the distance from the soma in
microns of the dendritic branching as well as the number of intersections per sholl for the
branches.

Figure 4. A photomicrograph of granule cells from the rat dendrite gyrus, as examined in this
study.
For the second neuronal population studied in this experiment, the CA1 pyramids of the
hippocampus, inhibition of PP2A with AAV resulted in a different pattern that presented itself
when analyzing the dendrate gyrus neuronal population. In this neuronal population AAV I2 FL
was the only PP2A inhibitor which resulted in significant dendritic atrophy (86% of total amount
dendritic length). No other AAV resulted in either a significant increase or decrease in dendritic
arbor.

Figure 5. CA1 pyramids of the hippocampus(basilar tree) were injected ICV with an AAV
expressing: Inhibitor 1 full length (I1 FL), Inhibitor 2 full length (I2 FL), Inhibitor 2 amino
terminal fragment (I2 NTF), and GFP (Green Fluorescent Protein) Control. The GFP is set at
100% as the standard.
Expression of Inhibition and Total Amount of Dendritic Arbor Length of Granule Cells
of CA1 pyramids of the hippocampus (basilar tree)
Expression

Total Amount Dendritic Length

GFP

100%

I1 FL

102%

I2 FL

86%

I2 TNF

103%

Table 2. The total amount of dendritic length was calculated in CA1 pyramids of the
hippocampus (basilar tree) after an AAV was injected ICV expressing: Inhibitor 1 full length (I1
FL), Inhibitor 2 full length (I2 FL), Inhibitor 2 amino terminal fragment (I2 NTF), and GFP
(Green Fluorescent Protein) Control

Figure 6. A photomicrograph of a CA1 pyramid of a rat hippocampus, as examined in the study.
As can be seen in comparing the two neuronal populations thus far, the CA1 pyramids of the
hippocampus (basilar tree) and the granule cells of the dendrite gyrus, these two neuronal
populations gave quite different patterns of dendritic branching alterations. Thus far, only one of
which, AAV I2 FL in CA1s pyramids, is associated with significant dendritic atrophy relative to
the control GFP group.
The third neuronal population examined in this study was the layer V pyramid cells of the
parietal cortex (basilar tree). In this neuronal population, the effect of PP2A inhibitors 1 and 2 in
the AAV treated rat yielded another pattern in cortical pyramids. Here, the GFP and I1 FL
groups have neurons with similar dendritic arbors at 100% and 98% respectively. However, both
I2 groups (I2FL and I2NTF) had larger dendritic arbors at 110% and 108% respectively.

Figure 7. Granule cells of the dendrite gyrus were injected ICV with AAV expressing: Inhibitor
1 full length (I1 FL), Inhibitor 2 full length (I2 FL), Inhibitor 2 amino terminal fragment (I2
NTF), and GFP (Green Fluorescent Protein) Control. GFP control is always set as 100% for
number of intersections per sholl as a standard.
Expression of Inhibition and Total Amount of Dendritic Arbor Length of Granule Cells
of the Layer V pyramids of the parietal cortex (basilar tree)
Expression

Total Amount Dendritic Length

GFP

100%

I1 FL

98%

I2 FL

110%

I2 NTF

108%

Table 3. The total amount of dendritic length was calculated in layer V pyramids of the parietal
cortex (basilar tree) after an AAV was injected ICV expressing: Inhibitor 1 full length (I1 FL),
Inhibitor 2 full length (I2 FL), Inhibitor 2 amino terminal fragment (I2 NTF), and GFP (Green
Fluorescent Protein) Control.

Figure 8. A photomicrograph of layer v pyramids of a rat parietal cortex, as examined in the
study.
All three neuronal populations examined in this study show three different patterns of
dendritic branching alterations. As with the comparison made between the first two neuronal
populations, and after incorporating the third neuronal population of the layer V pyramids of the
parietal cortex, there is only one expression in one cell type (AAV I2 FL of the CA1s) that
showed significant decrease in total amount of dendritic length relative to the GFP control group.
Nevertheless, these results represent an initial important assessment which may help us to
understand potentially alternative etiopathological mechanisms associated with AD. Other
ongoing investigations are currently also evaluating changes in dendritic spines in these same
neuronal populations. Taken together, they may serve to better characterize and/or validate this
novel animal model of AD as well as suggest novel therapeutic strategies to treat this devastating
disease.
Discussion AD is major health concern, as more and more individuals continue to be afflicted
by this devastating disease. By 2050 the number of people suffering from AD is approximated to
be around 100 million, more than 3 times greater than the population currently suffering from
AD (1). The staggering potential of AD patients to increase by more than 3 fold over the next 40
years could possibly be curbed if new drugs become available that can prevent or cure the
disease. A significant step in the development of possible drugs to curb the increase in
individuals afflicted with AD throughout the world, is illumination of mechanisms causing AD
and developments of new tauopathy animal models.
An agreed upon key in the development and mechanism of AD is the hyperphosphorylation of tau, thus depressing its activity and causing it to accumulate and aggregate
into clumps of PHF and eventually playing a significant role in causing NFT, a pathological
hallmark of AD (2). Several previous studies show that out of the 4 different classes of PP, PP2A
is involved with regulating the phosphorylation of tau. Thus this study aims at a relatively novel
technique in using AAV inhibitors injected ICV to cause downregualtion of PP2A and as a result
hyperphosphoryaltion of tau. The hyperphosphoryaltion of tau eventually plays a crucial role in

the development of NFTs; therefore developing a quite new tauopathic animal model of AD that
can be further studied for mechanism and drug design regarding AD.
The present study aims to quantify and compare the total amount of dendritic length of
the basilar tree in three different neuronal populations using GFP at 100% as the control group in
all three populations. The results were a bit atypical from what was hypothesized. The inhibition
of PP2A by the AAV inhibitors causes an increase in hyerphosphorylation of tau, and eventually
NFTs as explained throughout this paper. Thus, due to the development of NFTs and the tangling
of the dendritic arbor, it was hypothesized that this would cause the dendritic arbor of the
neuronal populations to be significantly smaller than the GFP control group of each neuronal
population. Since the GFP control group is set at 100% for the total amount of dendritic length as
a means of standard, it was hypothesized that the inhibitors: I1 FL, I2 FL, and I2 NTF would all
show a significant decrease in total amount of dendritic length in all three neuronal populations.
Thus far in all 3 neuronal populations examined in this study, three different patterns
were identified in each of the neuronal populations for the three different inhibitors expressed.
This is an initial development in a novel way of using an AAV method for expression of
inhibition in an animal model, as opposed to using a transgenic or knockout animal method to
study AD. It is also very important to note that the morphology and dendritic branching of the
three neuronal populations were taken and examined as a snapshot when the animals were
between 11-13 months old, with the average age being 12 months old. This is significant, as it is
still currently unclear when NFTs first start to develop in AD patients and AD animal models,
though it is traditionally believed to be quite early in the AD process (6). Future beneficial
studies may involve examining the animal not at one snapshot in time, but as a longitudinal study
and over a greater period of time when the neuronal populations can be examined at multiple
different times after being injected with the AAV.
AD is known to cause neuronal death and neuronal loss in individuals afflicted with AD.
It is known that as NFTs increase that neuronal death also increases, though it has been shown
that there is significant neuron loss before NFTs develop as well. Thus it is believed that some
other factor is primarily responsible for the bulk of neuron loss and previous studies show that
NFTs account for a small percentage (around 8.1%) of the neuron loss due to AD (6). Novel
research has brought to light the possibility of a phenomenon called compensatory hypertrophy
that may occur in the brain with neurons. In this phenomenon, as more and more neurons die and
neuron loss increases due to AD, the dendritic arbor of the surrounding neurons actually increase
in length to fill the void left by the surrounding dying neurons. Future studies are being done on
compensatory hypertrophy involved with neuronal loss and could be significant in explanation of
these results. Studies on compensatory hypertrophy and that phenomenon were not incorporated
in the present study, though it is of great interest for future endeavors. Multiple future studies are
required to validate and better understand these results and other results that have been gathered
from studies involving PP2A inhibition and hyperphosphorlation of tau in rat models of AD.
Using this new technique of using AAV for expression of inhibition of PP2A, in a tauopathy rat
model, provides a beginning to a feasible approach for understanding the complexity of AD.
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